For personal use only

Hygrovest Limited

Suite 5706, Level 57, MLC Centre

19-29 Martin Place

Sydney NSW Australia 2000

www.hygrovest.com.au

info@hygrovest.com.au

ASX RELEASE

21 July 2022

PRESENTATION FOR HGV WEBINAR - 22 JULY 2022

Hygrovest Limited (ASX:HGV) ("HGV") is an Australian-listed specialist investment company which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and other financial assets.

HGV Webinar Presentation

On 15 July 2022 HGV announced it is hosting a live audio webinar of the HGV Investor Conference Call on 22 July 2022.

HGV has enclosed the attached presentation which includes a presentation from Weed Me for the Investor Conference Call on Friday, 22 July 2022.

The Investor Conference Call will be conducted via Finance News Network.

In this webinar, Michael Curtis, HGV Non-Executive Director and Managing Partner of Parallax Ventures Inc and Mohan Nair, Chief Investment Partner of Parallax Ventures Inc, the asset manager of HGV's investments, will give an update on the following:

  • HGV Investment Outlook
  • Update on Major Investments
  • 30 June 2022 NTA

Also presenting at this webinar is Terry Kulaga, Chief Executive Officer and Co-founder of Weed Me.

To pre-register for the call, please follow the link below:

https://hygrovest.com.au/webinar/

Once registered, you will receive a confirmation email message that contains detailed information about joining the event.

Access to the audio webcast will open at 10.45 AM AEST on the day and the live stream is scheduled to begin at 11.00 AM AEST.

Investors are encouraged to provide questions in advance to info@hygrovest.com.au.

About Weed Me

Established in 2016, Weed Me is the largest unlisted Canadian licenced producer of cannabis products for the Canadian recreational market.

The Weed Me brand consists of a complete line of dried flower, pre-rolls, vapes, and gummies products, which have significant market shares in its key Canadian provincial markets. Weed Me has successfully expanded its operations with net sales of CAD22.7m in the year ended 31 December 2021 (FY21) compared to FY20 net sales of CAD6.9m and was profitable in FY21. Net sales growth continues with the

For personal use only

net sales of approximately CAD34m in the twelve months ended 30 June 20221 (representing a 180% increase over the net sales of CAD12m for the twelve months ended 30 June 2021).

HGV made its initial investment in Weed Me in December 2017. HGV's investment in Weed Me now has a current book value of CAD10m2 and comprises:

  1. 3.642m shares representing approximately 14% of Weed Me's issued capital (HGV has a book value of CAD1.62 per share);
  2. 460,830 warrants each convertible at CAD2.17 with an expiry date of 29 October 2024; and
  3. CAD2m convertible note which is unsecured, bears interest at a rate of 8% per annum, repayable on 29 April 2023 and has an option to convert into 1,197,604 Weed Me shares at CAD1.67 per share.

- - - - - - - - - -

Investor and Media Enquiries

Announcement authorised for release to ASX by:

Jim Hallam

Chief Financial Officer and Company Secretary

E: Compsec@hygrovest.com.au

  1. Based on unaudited Weed Me management accounts for the period
  2. Refer June 2022 Portfolio Update for valuation methodology

Hygrovest Limited

2

For personal use only

About HGV

Hygrovest Limited (ASX:HGV) ("HGV") (ABN 91 601 236 417) is an Australian-listed specialist investment company which concentrates on producing capital growth for shareholders over the medium to long term from investments in listed and unlisted equities and other financial assets.

Important Notice

This announcement contains reference to certain intentions, expectations, future plans, strategy and prospects of HGV. Those intentions, expectations, future plans, strategy and prospects may or may not be achieved. They are based on certain assumptions, which may not be met or on which views may differ and may be affected by known and unknown risks. The performance and operations of HGV may be influenced by a number of factors, many of which are outside the control of HGV. No representation or warranty, express or implied, is made by HGV, or any of its directors, officers, employees, advisers or agents that any intentions, expectations or plans will be achieved either totally or partially or that any particular rate of return will be achieved. Given the risks and uncertainties that may cause HGV's actual future results, performance or achievements to be materially different from those expected, planned or intended, recipients should not place undue reliance on these intentions, expectations, future plans, strategy and prospects. HGV does not warrant or represent that the actual results, performance or achievements will be as expected, planned or intended. Nothing in this material should be construed as either an offer to sell or a solicitation of an offer to buy or sell securities. It does not include all available information and should not be used in isolation as a basis to invest in HGV. This document does not constitute any part of any offer to sell, or the solicitation of an offer to buy, any securities in the United States or to, or for the account or benefit of any "US person" as defined in Regulation S under the US Securities Act of 1993 ("Securities Act"). HGV's shares have not been, and will not be, registered under the Securities Act or the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold in the United States or to any US person without being so registered or pursuant to an exemption from registration including an exemption for qualified institutional buyers.

Hygrovest Limited

3

ersonal use only

Shareholder Update Presentation

22 July 2022

© 2022 Hygrovest | ASX: HGV | www.hygrovest.com.au

DISCLAIMER

This presentation and the presentation materials (together, the Presentation) have been prepared by Hygrovest Limited (Company) (ABN 91 601 236 417). By receiving the Presentation, you acknowledge and represent to the Company that you have read, understood and accepted the terms of this disclaimer. It is the responsibility of all recipients of the Presentation to obtain all necessary approvals to receive the Presentation and receipt of the Presentation will be taken by the Company to constitute a representation and warranty that all relevant approvals have been obtained. All information is unaudited unless otherwise stated.

SUMMARY INFORMATION

The information in the Presentation is of a general nature and does not purport to contain all the information that;

  1. a prospective investor may require in connection with any potential investment in the Company; or
  2. would be required in a prospectus or product disclosure statement or other offering document prepared in accordance with the requirements of Australian law or the laws of any other jurisdiction, including the United States of America.

You should not treat the contents of the Presentation, or any information provided in connection with it, as financial advice, financial product advice or advice relating to legal, taxation or investment matters. The Presentation is not intended to be used for the basis of onlymaking an investment decision.

This Presentation is provided expressly on the basis that, before making any investment decision, you will carry out your own independent inquiries into the matters contained in the Presentation and will make your own independent decisions about the affairs, financial position or prospects of the Company. The Company reserves the right to update, amend or supplement the information at any time in its absolute discretion (without incurring any obligation to do so).

NOT AN OFFER

The Presentation is for information purposes only. The Presentation does not comprise a prospectus, product disclosure statement or other offering document under Australian law (and will not be lodged with the Australian Securities and Investments Commission)

or a y other law. The Presentation also does not constitute or form part of any invitation, offer for sale or subscription or any solicitation for any offer to buy or subscribe for any securities nor shall they or any part of them form the basis of or be relied upon in c nnection therewith or act as any inducement to enter into any contract or commitment with respect to securities.

FUTURE MATTERS

Certain statements contained in the Presentation, including information as to the future financial or operating performance of the Company and its investments, are forward looking statements. Such forward looking statements:

(a)

are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant technical, business, economic, competitive, political and social uncertainties and contingencies;

(b) involve known and unknown risks and uncertainties that could cause actual events or results to differ materially from estimated or anticipated events or results reflected in such forward looking statements; and

use

may include, among other things, statements regarding estimates and assumptions in respect of prices, costs, results and capital expenditure, and are or may be based on assumptions and estimates related to future technical, economic, market, political,

(c)

social and other conditions.

The Company disclaims any intent or obligation to publicly update any forward looking statements, whether as a result of new information, future events or results or otherwise. The words "believe", "expect", "anticipate", "indicate", "contemplate", "target", "plan", "intends", "continue", "budget", "estimate", "may", "will", "schedule" and similar expressions identify forward looking statements. All forward looking statements contained in the Presentation are qualified by the foregoing cautionary statements. Recipients are cautioned that forward looking statements are not guarantees of future performance and accordingly recipients are cautioned not to put undue reliance on forward looking statements due to the inherent uncertainty therein.

NO LIABILITY

The Company has prepared the Presentation based on information available to it at the time of preparation. No representation or warranty, express or implied, is made by the Company, or any of its directors, officers, employees, advisers or agents:

(a) as to the fairness, accuracy, completeness or reasonableness of the information, conclusions, statements, opinions or matters (express or implied) arising out of, contained in or derived from this Presentation or provided in connection with it, or any omission from this Presentation;

  1. as to the attainability of any estimates, forecasts or projections set out in this Presentation; or

(b) that any intentions, expectations or plans will be achieved either totally or partially or that any particular rate of return will be achieved. ersonal

Given the risks and uncertainties that may cause the Company's actual future results, performance or achievements to be materially different from those expected, planned or intended, recipients should not place undue reliance on these intentions, expectations, future plans, strategy and prospects. The Company does not warrant or represent that the actual results, performance or achievements will be as expected, planned or intended.

To the maximum extent permitted by law, the Company, its related bodies corporate, directors, officers, their advisers, agents and employees of those entities do not accept any responsibility or liability including, without limitation, any liability arising from fault or egligence on the part of any person, for any loss arising from the use of the Presentation or its contents or otherwise arising in connection with it.

Such responsibility or liability is, to the maximum extent permitted by law, expressly disclaimed and excluded.

US DISCLOSURE

This document does not constitute any part of any offer to sell, or the solicitation of an offer to buy, any securities in the United States or to, or for the account or benefit of any "US person" as defined in Regulation S under the US Securities Act of 1993 (Securities Act). The Company's shares have not been, and will not be, registered under the Securities Act or the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold in the United States or to any US person without being so registered or pursuant to an exemption from registration including an exemption for qualified institutional buyers.

2

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Hygrovest Ltd. published this content on 21 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 July 2022 22:33:05 UTC.